California Fertility Clinic (RMA Southern California) — An Independent Overview

RMA Southern California, operating under its original California Fertility Clinic, Inc. identity, is one of the longest-standing fertility practices in the Los Angeles area and a member of the RMA Network — a group of independent fertility clinics sharing clinical protocols, laboratory standards, and outcomes benchmarking across multiple U.S. markets. The practice's flagship Los Angeles office is located at 11500 W Olympic Blvd., Suite 150, a central Westside address that draws patients from Santa Monica, Beverly Hills, Culver City, and the broader Los Angeles Basin. A second location opened in Burbank in 2025, at 2601 W. Alameda Avenue, Suite 404, extending the practice's reach into the San Fernando Valley. For patients researching all available options in the state, our guide to California fertility clinics offers a broader comparison of programs across the region.

The clinic has earned recognition from multiple patient quality programs, including the Healthgrades Patients' Choice Award, the Super Doctors Award for Southern California (2024), and Forbes recognition, and has been designated a top performer by the Human Rights Campaign Foundation's Healthcare Equality Index for LGBTQ+ care. The practice's in-house embryology laboratory, on-site surgical center, and Artemis patient portal — which allows direct messaging with the physician team — distinguish it from many fertility practices where patients navigate third-party labs or intermediary call centers. For patients considering IVF treatment, having a fully integrated facility under one roof meaningfully reduces the logistical burden of a multi-step process.

Physicians and Clinical Team

RMA Southern California's Los Angeles and Burbank locations are staffed by three fellowship-trained reproductive endocrinologists, all of whom hold board certification in Reproductive Endocrinology and Infertility from the American Board of Obstetrics and Gynecology. The practice also maintains a dedicated genetic counseling team — an in-house resource that is relatively uncommon at smaller fertility clinics.

Thomas J. Kim, MD is a founding figure of the Los Angeles practice and has built a regional reputation across more than two decades of clinical work in reproductive medicine. Dr. Kim is board-certified in Reproductive Endocrinology and Infertility and holds the additional credential of High-Complexity Clinical Laboratory Director in Embryology — a certification that reflects his direct oversight of the in-house IVF laboratory and is required under federal CLIA (Clinical Laboratory Improvement Amendments) regulations for high-complexity lab directors. He is also a Certified Medical Technologist, a scientific credential that underscores his hands-on technical background in laboratory sciences. Dr. Kim is fluent in Korean and English, offering Los Angeles's large Korean-American community access to care in their first language. He provides telehealth consultations in addition to in-person appointments and has appeared in video educational content addressing complex topics such as single embryo transfer, chromosomal screening, and miscarriage prevention.

Melanie F. Landay, MD is a board-certified reproductive endocrinologist who has described her path to fertility medicine as a calling. Dr. Landay holds board certification in Reproductive Endocrinology and Infertility and practices at the Los Angeles location. She has been recognized by the Super Doctors Award for Southern California, a peer-nominated designation that reflects recognition within the regional medical community. Her clinical interests span the full range of reproductive medicine, with particular attentiveness to the emotional dimensions of infertility diagnosis and treatment.

Keri Bergin, MD is the third reproductive endocrinologist on the Los Angeles and Burbank team. Dr. Bergin is board-certified in Reproductive Endocrinology and Infertility and joined the practice as the San Fernando Valley patient base was expanding with the opening of the Burbank location. Her presence allows the practice to offer patients more scheduling flexibility across both campuses while maintaining continuity of care.

In addition to the physician team, RMA Southern California employs three dedicated genetic counselors on staff: Amber Kaplun, Allison "Alleigh" Boyd, and Deena Dubrow (Associate Genetic Counselor). Having certified genetic counselors integrated into the clinical team — rather than outsourced or referred — allows for same-institution coordination of preimplantation genetic testing, carrier screening interpretation, and pregnancy loss counseling.

Services and Treatments

RMA Southern California offers a full spectrum of fertility diagnostics and treatments, with all core services performed on-site at the Los Angeles location:

• In Vitro Fertilization (IVF), including fresh and frozen embryo transfers (FET)
• Intrauterine Insemination (IUI)
• Intracytoplasmic Sperm Injection (ICSI)
• Preimplantation Genetic Testing for Aneuploidies (PGT-A) and other indications
• Elective egg freezing and fertility preservation
• Ovulation induction and ovarian stimulation
• Hysterosalpingogram (HSG) and saline infusion sonohysterography (SIS)
• Male factor infertility evaluation and treatment
• Donor egg and donor sperm cycles
• Third-party reproduction coordination, including gestational surrogacy
• LGBTQ+ family building, including reciprocal IVF and sperm-donor cycles
• Oncofertility and fertility preservation for patients facing cancer treatment
• Reproductive surgery for structural causes of infertility
• Comprehensive carrier screening and genetic counseling
• Telehealth consultations for initial visits and follow-ups

The LGBTQ+ program is a meaningful part of the practice's patient mix. RMA Southern California's Human Rights Campaign Foundation Healthcare Equality top performer designation reflects formal evaluation of its policies, staff training, and patient experience protocols for LGBTQ+ patients — not simply a self-reported claim. For same-sex female couples, reciprocal IVF (where one partner provides eggs and the other carries the pregnancy) is available. Gay male couples seeking a gestational carrier can access coordination services through the practice.

Laboratory and Success Rates

The Los Angeles location houses an in-house IVF laboratory and surgical center, allowing egg retrievals, embryo culture, and embryo transfers to occur within a single facility. Dr. Kim's role as a CLIA-certified High-Complexity Clinical Laboratory Director in Embryology means the physician team maintains direct oversight of laboratory quality — an arrangement that contrasts with practices that rely on shared or contracted embryology services. The laboratory uses continuous environmental monitoring and modern cryostorage systems to maintain the controlled conditions that embryo culture requires.

As a member of the RMA Network, RMA Southern California participates in network-wide outcomes tracking and protocol standardization, providing an external quality benchmark beyond what individual clinics establish internally. RMA Network practices are members of the Society for Assisted Reproductive Technology (SART), and outcomes data is reported to SART and the CDC's National ART Surveillance System (NASS) — the federal database maintained by the Centers for Disease Control and Prevention. Prospective patients can review independently verified success rates for this clinic, broken down by patient age group and cycle type, through the SART Clinic Summary Report database and the CDC ART national reporting page. These public databases are the most reliable basis for comparing outcomes across clinics, since they are audited and standardized across all reporting practices.

Patient Experience

The Los Angeles office at 11500 W Olympic Blvd is accessible from the 10 and 405 freeways, with a Westside location that serves a wide swath of the Los Angeles metro. The Burbank location, which opened in 2025, extends the practice's geographic footprint into the Valley, reducing drive times for patients in Burbank, Glendale, Studio City, and surrounding communities.

The practice's Artemis patient portal is one of its more distinctive operational features. Rather than routing patient questions through a general nurse line or call center, Artemis allows patients to message their physician team directly — a communication model that several patient reviewers have specifically cited as reducing the anxiety associated with waiting for answers during a treatment cycle. Telehealth appointments are available for consultations and follow-ups, allowing patients to manage portions of their care without traveling to the office.

Patient reviewers on Healthgrades and other platforms consistently note the professionalism of the front office staff, the attentiveness of the nursing team, and the clarity of communication during treatment cycles. The practice's Healthgrades Patients' Choice Award reflects sustained positive patient feedback over multiple review cycles. Patients who speak Korean will find Dr. Kim available in their language, which is a meaningful accessibility feature in one of the largest Korean-speaking communities outside of South Korea.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Financing

California does not have a comprehensive state fertility insurance mandate that applies to all private health plans, which means coverage for IVF and related treatments varies significantly depending on a patient's employer and specific health plan. However, California does require insurers to cover fertility preservation services for patients facing iatrogenic infertility — meaning patients whose fertility may be compromised by cancer treatment or other medical procedures are entitled to coverage for egg or embryo freezing under many California health plans. Additionally, California law requires insurance coverage for the diagnosis of infertility, though coverage for treatment remains plan-dependent.

RMA Southern California accepts a wide range of insurance carriers, including Aetna, Anthem, Blue Shield of California, Cigna, United Healthcare, and others. For patients whose plans do not cover treatment, the practice offers several financial programs designed to reduce upfront cost and out-of-pocket exposure:

• CareShare IVF Refund Guarantee Program — a multi-cycle program that provides a refund if treatment does not result in a live birth, allowing patients to share financial risk with the clinic
• Discounted fertility testing package — comprehensive initial diagnostic testing available at a reduced flat rate
• Multi-cycle discount program — reduced per-cycle pricing for patients committing to multiple IVF cycles
• Semen Analysis Continuing Care Program — includes a $150 credit toward treatment for patients completing initial semen analysis

Financing partnerships with third-party lenders are available for patients who need to spread treatment costs over time. The practice's financial counselors can review a patient's specific insurance benefits before treatment begins and provide out-of-pocket estimates based on the recommended treatment plan.

Frequently Asked Questions

What is the difference between RMA Southern California and California Fertility Clinic, Inc.? California Fertility Clinic, Inc. is the legal entity name under which the Los Angeles practice was originally incorporated. The clinic now operates publicly as RMA Southern California, reflecting its affiliation with the RMA Network. For practical purposes — scheduling, insurance billing, and clinical care — the two names refer to the same practice at the same Los Angeles address.

Does RMA Southern California accept LGBTQ+ patients, and what specific services are available? Yes. The clinic has been designated a top performer by the Human Rights Campaign Foundation's Healthcare Equality Index, which evaluates both policy and practice. Services for LGBTQ+ patients include reciprocal IVF for same-sex female couples, donor sperm IUI and IVF, gestational carrier coordination for patients using a surrogate, and single-parent family building pathways. Staff training in LGBTQ+ affirming care is a formal part of the clinic's operations.

How can I verify the clinic's IVF success rates independently? RMA Southern California reports its outcomes data to SART (Society for Assisted Reproductive Technology) and the CDC. Both organizations publish clinic-specific summaries broken down by patient age group, cycle type, and diagnosis. These are the most reliable sources for comparing success rates across clinics, as they are standardized and audited. You can access this data at the SART Clinic Summary Report database or the CDC ART national reporting page — both linked in the Laboratory and Success Rates section above.

What is the CareShare IVF Refund Guarantee Program? CareShare is RMA Southern California's multi-cycle financial program that provides a partial or full refund if treatment cycles do not result in a live birth. Eligibility requirements apply and typically include age limits and ovarian reserve thresholds. Patients interested in CareShare should ask about current eligibility criteria during their initial consultation, as program terms can change. For patients who may need multiple cycles, CareShare can meaningfully reduce the total financial risk of pursuing IVF treatment.